{"entity":{"type":"insider","cik":"0001859284","url":"/insider/0001859284","json_url":"/insider/0001859284.json","name":"Morabito Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2021-06-29","last":"2024-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Morabito Christopher","source":"filing","n_filings":3,"first_seen":"2021-06-29","last_seen":"2024-04-03"}],"transactions":[{"id":3268386,"accession":"0001104659-24-043092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-043092","line_url":"/filing/0001104659-24-043092#line-2","is_derivative":false,"issuer_cik":"0001454789","issuer_name":"Astria Therapeutics, Inc.","issuer_ticker":"ATXS","issuer_name_source":null,"issuer_url":"/issuer/0001454789","owner_cik":"0001859284","owner_name":"Morabito Christopher","owner_url":"/insider/0001859284","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.5939,"price_display":"13.59","price_state":"stated","total_value":135939.0,"total_display":"135,939.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":2753331,"accession":"0001104659-24-008327","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-008327","line_url":"/filing/0001104659-24-008327#line-4","is_derivative":false,"issuer_cik":"0001454789","issuer_name":"Astria Therapeutics, Inc.","issuer_ticker":"ATXS","issuer_name_source":null,"issuer_url":"/issuer/0001454789","owner_cik":"0001859284","owner_name":"Morabito Christopher","owner_url":"/insider/0001859284","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":11.147,"price_display":"11.15","price_state":"stated","total_value":102552.4,"total_display":"102,552.40","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-30","scope":"insider"},{"id":2753323,"accession":"0001104659-24-008327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-008327","line_url":"/filing/0001104659-24-008327#line-2","is_derivative":false,"issuer_cik":"0001454789","issuer_name":"Astria Therapeutics, Inc.","issuer_ticker":"ATXS","issuer_name_source":null,"issuer_url":"/issuer/0001454789","owner_cik":"0001859284","owner_name":"Morabito Christopher","owner_url":"/insider/0001859284","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":11.015,"price_display":"11.02","price_state":"stated","total_value":8812.0,"total_display":"8,812.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-30","scope":"insider"},{"id":5132211,"accession":"0000899243-21-026557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-026557","line_url":"/filing/0000899243-21-026557#line-1","is_derivative":false,"issuer_cik":"0001680581","issuer_name":"Fulcrum Therapeutics, Inc.","issuer_ticker":"FULC","issuer_name_source":null,"issuer_url":"/issuer/0001680581","owner_cik":"0001859284","owner_name":"Morabito Christopher","owner_url":"/insider/0001859284","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":9.16,"price_display":"9.16","price_state":"stated","total_value":10076.0,"total_display":"10,076.00","shares_owned_after":1100.0,"shares_owned_after_display":"1,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001454789","name":"Astria Therapeutics, Inc.","url":"/issuer/0001454789","role":"Officer (Chief Medical Officer)","n_filings":2,"first_seen":"2024-01-30","last_seen":"2024-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001680581","name":"Fulcrum Therapeutics, Inc.","url":"/issuer/0001680581","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2021-06-29","last_seen":"2021-06-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001859284","retrieved_at":"2026-08-21T01:32:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}